Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,944.80
(
0.67%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.73
(
0.75%
)
Bitcoin
78,009.38
(
2.20%
)
News Focus
News Focus
Post# of 1309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MacTheKnife

Send PM Follow Ignore
Followers 1
Posts 17
Boards Moderated 0
Alias Born 08/14/2009

MacTheKnife

Re: tnzalu post# 189

Wednesday, 11/11/2009 1:29:52 PM

Wednesday, November 11, 2009 1:29:52 PM

Post# of 1309
tnzlu,

Good summary. You miss one key point:

CEO stated that the next trial would be either a Ph 2 confirmatory trial OR else a Phase 2/3 trial. It seems to me that the partners want to move this along a little quicker than we might have expected.

Imagine CEO announces tomorrow that Novartis has paid 50m up front to partner Tovaxin and is going straight into a Phase 3 trial? Can you see the share price reaction? I can!

Mac
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote